Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B-Reference-Cited by-同舟云学术

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B

Published:2013-07-29 Issue:8 Volume:19 Page:887-895
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Perrillo Robert¹,Buti Maria²,Durand Francois³,Charlton Michael⁴,Gadano Adrian⁵,Cantisani Guido⁶⁷,Loong Che‐Chuan⁸,Brown Kimberly⁹,Hu Wenhua⁹,Lopez‐Talavera Juan Carlos⁹,Llamoso Cyril⁹

Affiliation:

1. Hepatology DivisionBaylor University Medical CenterDallas TX

2. Liver UnitVall d'Hebron University General Hospital/Network Center for Biomedical Research in Hepatic and Digestive Diseases, Carlos III InstituteBarcelona Spain

3. Hepatology Service, National Institute of Health and Medical Research CRB3, Beaujon HospitalUniversity of Paris VIIClichy France

4. Division of Gastroenterology and HepatologyMayo ClinicRochester MN

5. Hepatology SectionItalian Hospital of Buenos AiresBuenos Aires Argentina

6. Liver Transplantation GroupSanta Casa Hospital ComplexPorto Alegre Brazil

7. Department of Surgery, School of MedicineFederal University of Rio Grande do SulPorto Alegre Brazil

8. Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, School of MedicineNational Yang‐Ming UniversityTaipei Taiwan

9. Research and DevelopmentBristol‐Myers Squibb CompanyWallingford CT

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.23690

Reference34 articles.

1. Hepatitis B: An important public health issue

2. Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective

3. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis

4. Prevention of post liver transplant HBV recurrence

5. A multicenter United States—Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation;Viruses;2023-04-23

2. High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis;Hepatology International;2023-01-02

3. Nucleosides and Nucleoside Analogues as Emerging Antiviral Drugs;Mini-Reviews in Organic Chemistry;2021-09-17

4. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation;Alimentary Pharmacology & Therapeutics;2021-07-19

5. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts;Liver International;2021-03-12